During the past decade, Hôpital Mère-Enfant conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Mère-Enfant" #1 sponsor was "Hospices Civils de Lyon" with 3 trials, followed by "Centre Oscar Lambret" with 2 trials sponsored, "Sunovion" with 2 trials sponsored, "ERYtech Pharma" with 1 trials sponsored and "Eisai Limited" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Mère-Enfant" #1 collaborator was "Anticancer Fund, Belgium" with 1 trials as a collaborator, "Biofortis Mérieux NutriSciences" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "CTD-CNO" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Mère-Enfant" are "Osteosarcoma" (2 trials), "Acetaminophen" (1 trials), "Acute Lymphoblastic Leukemia, in Relapse" (1 trials), "Aggressive Fibromatosis" (1 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Hôpital Mère-Enfant" in a lesser frequency.

Most popular intervention types in "Hôpital Mère-Enfant" are "Drug" (7 trials), "Other" (4 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood test" (2 trials), "Placebo" (2 trials), "Acetaminophen" (1 trials), "Blood sampling (facultative)" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Mère-Enfant" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Mère-Enfant". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hôpital Mère-Enfant, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Mère-Enfant, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".